Aurealis Therapeutics is a Swiss-Finnish clinical-stage company developing multi-target bacterial gene therapies using genetically engineered Lactococcus cremoris
Aurealis Therapeutics is a Swiss-Finnish clinical-stage company developing multi-target bacterial gene therapies using genetically engineered Lactococcus cremoris. The company focuses on developing curative therapies for chronic wounds, cancer, and inflammatory diseases.